Phase I/II Study Of Neoadjuvant mFOLFIRINOX In Combination With Peri-Operative Oral Hydroxychloroquine (FHQ) In Patients With Resectable Adenocarcinoma Of The Pancreas
Summary
The purpose of this phase I/II study is to evaluate the safety and tolerability of modified FOLFIRINOX in combination with oral hydroxychloroquine (FHQ) in the treatment of patients with resectable adenocarcinoma.
General Information
NCT#: NCT04911816
Study ID: 2103260669
Trial Phase: Phase I/II
Trial Sponsor: West Virginia University
Therapies Used in This Trial: Hydroxychloroquine, FOLFIRINOX